Advertisement

Lymphadenopathy Associated Virus (L.A.V.) : Its Association with AIDS or Prodromes

  • Françoise Barré-Sinoussi
  • Jean-Claude Chermann
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 187)

Abstract

In testing the hypothesis that retroviruses could be involved in AIDS or AIDS related complexe (ARC), we isolated in 1983 a T lymphotropic retrovirus from a homosexual man presenting with lymphadenopathy ( 1 ) . This virus was shown to be a retrovirus by all classical criteria (density in sucrose gradient, high molecular weight RNA, reverse transcriptase activity, morphogenesis by budding) ( 2 )( 3 ). This first isolate was named Lymphadenopathy Associated Virus (LAV 1). Latter on similar viruses were obtained by our group ( 4 )( 5 )( 6 ) and by others from patients with AIDS or related symptoms ( 7 ) ( 8 ) ( 9 ).

Keywords

Acquire Immunodeficiency Syndrome Reverse Transcriptase Activity AIDS Related Complexe Sodium Hypochloride Release Virus Particle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    F. Barre-Sinoussi, J.C. Chermann, F. REY et al., Isolation of a T-lymphotropic retrovirus from a patient at risk of acquired immunodeficiency syndrome. Science, 220: 868 (1983).PubMedCrossRefGoogle Scholar
  2. 2.
    J.C. Chermann, F. Barre-Sinoussi and L. Montagnier. Characterisation and possible role in AIDS of a new human T-lympho- tropic retrovirus. In: Acquired immune deficiency syndrome. ÜCLA Symposia on molecular and cellular biology. New series, Volume 16, Eds. M.S. Gottlieb and J.E. Groopman, Alan R. Liss Inc., New York, N.Y. 31, (1984).Google Scholar
  3. 3.
    F. Barre-Sinoussi, J.C. Chermann And L. Montagnier. A new human retrovirus associated with acquired immunodeficiency syndrome (AIDS) or AIDS-related symptoms. In: Manipulation of host defense mechanisms. Ed. Tadao Aoki(JAPAN), 1 vol. (1984), in press.Google Scholar
  4. 4.
    L. Montagnier, J.C. Chermann, F. Barre-Sinoussi, A new human T-lymphotropic retrovirus: characterisation and possible role in lymphadenopathy and acquired immune deficiency syndromes. Cold Spring Harbor publication - Meeting on “Human T-cell leukemia viruses”, 1 vol., 363, (1984)Google Scholar
  5. 5.
    E. Vilmer, F. Barre-Sinoussi, C. Rouzioux, Isolation of new lymphotropic retrovirus from two siblings with hemophilia B, one with AIDS. Lancet,i, 753, (1984).Google Scholar
  6. 6.
    A. Ellrodt, F. Barre-Sinoussi, P. Le Bras, Isolation of a new human T-lymphotropic retrovirus (LAV) from a mariried couple of Zairians, one with AIDS, the other with prodromes. Lancet, i, 1383, (1984).Google Scholar
  7. 7.
    R.C. Gallo, S.Z. Salahuddin, M. PopoviC et al. Frequent de-tection and isolation of cytopathic retrovirus (HTLV III) from patients with AIDS and at risk for AIDS. Science, 224, 500, (1984).PubMedCrossRefGoogle Scholar
  8. 8.
    M. Popovic, M.G. Sarngadharan, E. Read And R.C. Gallo. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV III) from patients with AIDS and pre-AIDS. Science, 224, 497, (1984).PubMedCrossRefGoogle Scholar
  9. 9.
    J.A. Levy, A.D. Hoffman, S.M. Kramer et al. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science, 225, 840, (1984).PubMedCrossRefGoogle Scholar
  10. 10.
    D. Klatzmann, F. Barre-Sinoussi, J.C. Chermann, Selec-tive tropism for the helper/inducer T-lymphocyte subset of a new human retrovirus associated with the acquired immunodeficiency syndrome. Science, 225, 59, (1984).Google Scholar
  11. 11.
    D. Klatzmann, E. Champagne, S. Chamaret et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV Nature, 312, 767, (1984).Google Scholar
  12. 12.
    A.G. DALGLEISH, P.C.L. Beverley, P.R. Clapham Et al. The CDA (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature, 312, 763, (1984).PubMedCrossRefGoogle Scholar
  13. 13.
    L. Montagnier, C. Dauguet, C. Axler, A new type of retrovirus isolated from patients presenting with lymphade- nopathy and acquired immune deficiency syndrome: Structural and antigenic relatedness with equine infectious anemia virus. Ann. Virol. (Institut Pasteur), 135 E, 119, (1984).Google Scholar
  14. 14.
    F. Barre-Sinoussi, J.C. Chermann And L. Montagnier. Analysis and Immunological properties of lymphadenopathy associated virus (LAV) structural proteins. Intern, symposium on retro-viruses and human pathology, Lerici (Italy), Sept. 1984, Humana Press Inc., (in press).Google Scholar
  15. 15.
    H. Towbin, T. Staehlin, J. Gordon. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets procedure and some applications. Proc. Natl. Acad. Sei. U.S.A., 76, 4350, (1979).Google Scholar
  16. 16.
    L. Montagnier, B. Krust, S.Chamaret Identification and antigenicity of the major envelope protein of lympha-denopathy associated virus (LAV). J. Virol., (1985), in press.Google Scholar
  17. 17.
    M. Alizon, P. Sonigo, F. Barre-Sinoussi Molecular cloning of lymphadenopathy associated virus. Nature, 312, 757, (1984).PubMedCrossRefGoogle Scholar
  18. 18.
    S. Wain-Hobson, P. Sonigo, O. Danos Nucleotide se-quence of the AIDS virus, LAV. Cell, 40, 9, (1985).Google Scholar
  19. 19.
    F. Brun-Vezinet, C. Rouzioux, F. Barre-Sinoussi Detection of IgG antibodies to lymphadenopathy associated virus (LAV) by ELISA, in patients with acquired immunodefi-ciency syndrome or lymphadenopathy syndrome.Lancet,i, 1253, (1984).Google Scholar
  20. 20.
    F. Brun-Vezinet, C. Rouzioux, L. Montagnier Preva-lence of antibodies to lymphadenopathy associated retro-virus in African patients with acquired immune deficiency syndrome. Science, 226, 453, (1984).Google Scholar
  21. 21.
    E. Melbye, R.J. Biggar, J.C. Chermann High preva-lence of lymphadenopathy virus (LAV) in European hemophi-liacs. Lancet, ii, 40, (1984).Google Scholar
  22. 22.
    M.P. Feorino, V.S. Kalyanaraman, H.W. Haverkos et al. Lymphadenopathy Associated Virus (LAV) infection of a blood donor-recipient pair with acquired immunodeficiency syndrome. Science, 225, 69, (1984).PubMedCrossRefGoogle Scholar
  23. 23.
    B. Spire, F. Barre-Sinoussi, L. Montagnier And J.C. Chermann Inactivation of Lymphadenopathy Associated Virus by chemical disinfectants. Lancet, ii, 899, (1984).Google Scholar
  24. 24.
    B. Spire, D. Dormont, F. Barre-Sinoussi Inactivation of Lymphadenopathy Associated Virus by heat, gamma rays, and ultraviolet light. Lancet, i, 188, (1985).Google Scholar
  25. 25.
    M.G. Sarngadharan, M. Popovic, L. Bruch et al. Antibodies reactive with human T-lymphotropic retroviruses (HTLV III) in the serum of patients with AIDS. Science, 224, 506, (1984)PubMedCrossRefGoogle Scholar
  26. 26.
    J. Schupbach, M. Popcvic, R.V. Gilden et al. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV III) associated with AIDS. Science, 224, 503, (1984).PubMedCrossRefGoogle Scholar
  27. 27.
    J.C. Chermann, M.S. Sarngadharan, F. Barre-Sinoussi (in preparation).Google Scholar
  28. 28.
    L. Ratner, W. Haseltine, R. Patarca et al. Complete nucleotide seguence of the AIDS virus, HTLV III. Nature, vol. 313, 600, 277, (1985).PubMedCrossRefGoogle Scholar
  29. 29.
    W. Rozenbaum, D. Dormont, B. Spire Antimoniotungstate ( HPA 23) treatment of 4 patients with AIDS or prodromes. Lancet, i,(1985), in press.Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Françoise Barré-Sinoussi
    • 1
  • Jean-Claude Chermann
    • 1
  1. 1.Unité d’Oncologie ViraleInstitut PasteurParis Cédex 15France

Personalised recommendations